BSE Live
Apr 13, 16:01Prev. Close
107.18
Open Price
105.16
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 13, 16:00Prev. Close
106.55
Open Price
105.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
106.29 (100)
| Cash Flow of Indo US Bio-Tech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 16.53 | 8.80 | 7.39 | 5.49 | 4.13 | |
| Net CashFlow From Operating Activities | 1.42 | -4.58 | 0.53 | 2.91 | 0.22 | |
| Net Cash Used In Investing Activities | -0.79 | 4.28 | -6.67 | -5.40 | -1.75 | |
| Net Cash Used From Financing Activities | -1.48 | 1.22 | 6.29 | 2.41 | 1.46 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.85 | 0.91 | 0.14 | -0.08 | -0.07 | |
| Cash And Cash Equivalents Begin of Year | 1.10 | 0.19 | 0.05 | 0.13 | 0.20 | |
| Cash And Cash Equivalents End Of Year | 0.25 | 1.10 | 0.19 | 0.05 | 0.13 |
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
13.04.2026
Jyoti CNC shares tumble 14% as French officials look into firm's arm for defying export rules
13.04.2026
Robust gold sales signal resilient consumer appetite, jewellers set for a strong Q4
13.04.2026
13.04.2026
12.02.2026
Q3 results impact: Avanti Feeds, Apex Frozen shares rally up to 19% to fresh record highs
11.02.2026
Titan shares rise 3% to new 52-week high as Q3 results impress: Check brokerages' target prices
10.02.2026
Titan Q3 Results: Net profit rises 61% to Rs 1,684 crore on high gold prices, revenue up 43%
10.02.2026
BSE shares jump 6% to fresh record high after strong Q3 results: Brokerages raise target prices
23.01.2026
Matrimony Q3 PAT may dip 21.8% YoY to Rs. 7.8 cr: ICICI Securities
23.01.2026
India Mart Q3 PAT seen up 27.5% YoY to Rs. 154.3 cr: ICICI Securities
23.01.2026
Just Dial Q3 PAT seen up 17% YoY to Rs. 153.6 cr: ICICI Securities
23.01.2026
Nykaa Q3 PAT seen up 105.7% YoY to Rs. 53.7 cr: ICICI Securities